Ozempic diabetes and weight loss medication under investigation after a few reports of suicidal thoughts
Fox News
The popular medications Ozempic and Saxenda from Novo Nordisk are being investigated after three people experienced an increase in thoughts of suicide and self-harm.
Three people reported the symptoms in Iceland — two linked to Ozempic, one to Saxenda — which sparked the EU’s safety review, according to multiple reports. "These drugs do affect hormones in the brain." Melissa Rudy is health editor and a member of the lifestyle team at Fox News Digital.
Both drugs are glucagon-like peptide 1 (GLP-1) agonists, which have the dual effect of controlling blood sugar and aiding in weight loss.
More Related News